HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,185-2,196 of 4,505
Drug study icon
CompletedNCT00566631

Paliperidone Extended-Release (ER) Tablets for schizophrenia

What is this study about?

Researchers studied Paliperidone to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Zagreb
SchizophreniaMedication studyAges 18+
Countries
France, Croatia, Germany, + 4 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedNCT01299389

Paliperidone Palmitate for schizophrenia

What is this study about?

Researchers compared Paliperidone palmitate and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Fujioka
SchizophreniaMedication studyAges 20+
Countries
Japan, South Korea, Taiwan
Sponsor
Janssen Pharmaceutical K.K.
Drug study icon
CompletedNCT01662310

An Efficacy Study of Paliperidone for the Prevention of Relapse in people with Schizophrenia

Official study title

Paliperidone Extended Release Tablets for the Prevention of Relapse in Subjects With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

This study has finished and is no longer accepting participants.

Multiple locations, including Baoding
SchizophreniaMedication studyAges 18+
Countries
China
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedNCT01895452

An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

What is this study about?

Researchers compared ALKS 9072, Low Dose and ALKS 9072, High Dose, tracking side effects to assess long-term safety in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–70
Countries
United States, Bulgaria, Malaysia, + 5 others
Sponsor
Alkermes, Inc.
Drug study icon
CompletedNCT01175135

Efficacy, Safety, And Tolerability Of PF-02545920 for schizophrenia

What is this study about?

Researchers compared PF-02545920, placebo and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States, Germany, Ukraine
Sponsor
Pfizer
Other study type icon
CompletedNCT01634542

An Non-Interventional Study of people with Persistent Symptoms of Schizophrenia

Official study title

A Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness

This study has finished and is no longer accepting participants.

Multiple locations, including Buenos Aires
SchizophreniaObservational studyAges 18+
Countries
France, Canada, United Kingdom, + 5 others
Sponsor
Hoffmann-La Roche
Other study type icon
TerminatedNCT01894984

Risperidone Long-Acting Injection for schizophrenia

Official study title

Clinical Observation of the Efficacy and Safety of Risperidone Long-Acting Injection (Risperdal Consta) in the Treatment of Schizophrenia in China

This study ended early.

Location not clearly listed
SchizophreniaObservational studyAges 18–65
Countries
Sponsor
Xian-Janssen Pharmaceutical Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.